ARTICLE | Clinical News
Apricitabine: Phase III started
January 7, 2008 8:00 AM UTC
Avexa began a double-blind, international Phase III trial to compare oral apricitabine given twice daily vs. lamivudine ( 3TC) in about 900 patients. Avexa has worldwide rights to apricitabine from Sh...